Skip to main content
. 2024 Apr 22;18(9):1486–1504. doi: 10.1093/ecco-jcc/jjae057

Table 2.

Pooled mean estimates of WPAI outcomes and indirect costs.

WPAI outcome No. of studies Pooled mean estimate [%] [95% CI] Heterogeneity [I2]
Absenteeism
 Total IBD 27 16.4 [13.9-18.9] 95.5
 CD only 13 18.9 [14.9-22.9] 93.3
 UC only 13 16.5 [13.0-20.1] 95.4
Presenteeism
 Total IBD 27 35.9 [31.1-40.7] 98.8
 CD only 13 41.3 [37.2-45.5] 94.9
 UC only 13 33.6 [27.8-39.5] 98.3
Overall work impairment
 Total IBD 27 39.4 [33.9-44.9] 98.9
 CD only 13 45.5 [40.0-50.9] 96.5
 UC only 12 38.0 [30.9-45.2] 98.6
Non-work activity impairment
 Total IBD 24 46.0 [39.5-52.5] 99.4
 CD only 12 52.6 [49.0-56.3] 95.7
 UC only 11 40.8 [32.2-49.5] 99.3
Indirect costsa No. of studies Pooled mean estimate [95% CI] [euro/patient/year] Heterogeneity [I2]
Absenteeism
 Total IBD 8 1,813.9 [907.8-2720.2] 98
 CD only 3 1,541.2 [955.1-2127.4] 79.1
 UC only 3 1,170.5 [395.8-1945.1] 97.7
Presenteeism
 Total IBD 6 3,562.5 [1,409.4-5,715.6] 99.3
Overall work impairment
 Total IBD 5 5,131.1 [800.9-9,461.3] 99.9

WPAI, Work Productivity and Activity Impairment questionnaire; IBD, inflammatory bowel disease; UC, ulcerative colitis; CD, Crohn’s disease.

aThere were not enough studies to determine pooled estimates of indirect costs separately for CD and UC with regards to presenteeism and overall work impairment.